Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)
Trial details
- Registry ID
- NCT07868939
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)NCT07868939 | VKTX | Phase 3 | Recruiting | 2028-10Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |